Literature DB >> 9758679

Enhanced skin permeation of sex hormones with novel topical spray vehicles.

T M Morgan1, B L Reed, B C Finnin.   

Abstract

The feasibility of using some novel topical spray vehicles for enhanced transdermal delivery of the sex hormones, testosterone (Tes), estradiol (E2), progesterone (Prog), and norethindrone acetate (NA) has been investigated. The new penetration enhancers, padimate O (PadO) and octyl salicylate (OSal) were used and compared with laurocapram (AZ) and oleic acid (OA). A finite dose (5 microL/cm2) of each vehicle was applied to either shed snake skin or swine skin in vitro, and the amount penetrated was measured with flow-through diffusion cells. Partitioning into swine skin was determined after an exposure time of 1 min. Rapid partitioning of Tes and PadO into swine skin occurred after 1 min with 70% and 60% of the applied dose, respectively, remaining in the skin after the unabsorbed dose was removed by rinsing with absolute ethanol. The cumulative amount at 24 h (Q24 h) of Tes penetrating across the snake skin was significantly enhanced (p < 0.05) up to 6-fold for OSal, 3-fold for OA and AZ, and 2-fold for PadO compared to control. Using PadO or AZ, the Q24 h ranged from three- to thirteen-fold over control (p < 0.05) for E2, Prog, and NA. Extrapolation of these data to predict what would happen in humans suggests that it should be possible to deliver clinically relevant amounts of sex hormones in this manner with once daily dosing.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9758679     DOI: 10.1021/js980025k

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

Review 1.  Testosterone hormone replacement therapy: state-of-the-art and emerging technologies.

Authors:  Marie-Laure Leichtnam; Hervé Rolland; Patrick Wüthrich; Richard H Guy
Journal:  Pharm Res       Date:  2006-06-09       Impact factor: 4.200

2.  Biodegradable β-Cyclodextrin Conjugated Gelatin Methacryloyl Microneedle for Delivery of Water-Insoluble Drug.

Authors:  Xingwu Zhou; Zhimin Luo; Avijit Baidya; Han-Jun Kim; Canran Wang; Xing Jiang; Moyuan Qu; Jixiang Zhu; Li Ren; Fereshteh Vajhadin; Peyton Tebon; Niyuan Zhang; Yumeng Xue; Yudi Feng; Chengbin Xue; Yi Chen; KangJu Lee; Junmin Lee; Shiming Zhang; Chun Xu; Nureddin Ashammakhi; Samad Ahadian; Mehmet Remzi Dokmeci; Zhen Gu; Wujin Sun; Ali Khademhosseini
Journal:  Adv Healthc Mater       Date:  2020-05-04       Impact factor: 9.933

Review 3.  Transdermal drug delivery.

Authors:  Mark R Prausnitz; Robert Langer
Journal:  Nat Biotechnol       Date:  2008-11       Impact factor: 54.908

4.  Effects of chemical enhancers on human epidermal membrane: Structure-enhancement relationship based on maximum enhancement (E(max)).

Authors:  Sarah A Ibrahim; S Kevin Li
Journal:  J Pharm Sci       Date:  2009-03       Impact factor: 3.534

Review 5.  Ultrasound-enhanced transdermal delivery: recent advances and future challenges.

Authors:  Matthias A Oberli; Carl M Schoellhammer; Robert Langer; Daniel Blankschtein
Journal:  Ther Deliv       Date:  2014-07

6.  Effects of solvent deposited enhancers on transdermal permeation and their relationship with Emax.

Authors:  Sarah A Ibrahim; S Kevin Li
Journal:  J Control Release       Date:  2009-02-06       Impact factor: 9.776

7.  Preparation and the biopharmaceutical evaluation for the metered dose transdermal spray of dexketoprofen.

Authors:  Wangding Lu; Huafei Luo; Zhuangzhi Zhu; Yubo Wu; Jing Luo; Hao Wang
Journal:  J Drug Deliv       Date:  2014-02-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.